Adalimumab

Common brands: Humira, Methotrexate, Rasuvo, Otrexup, Trexall

Top reporter: Abbvie Inc.

Folate Analog Metabolic Inhibitor [EPC]Tumor Necrosis Factor Blocker [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Vitamin C [EPC]
699,270
Total Reports
199,753
Serious Reports
29,476
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (4.22%)

Patient Demographics

Male
210,757
Female
448,464

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Adalimumab.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 91,120
11.5%
2 PAIN 49,355
6.2%
3 ARTHRALGIA 48,311
6.1%
4 INJECTION SITE PAIN 47,302
5.9%
5 FATIGUE 39,344
4.9%
6 RHEUMATOID ARTHRITIS 35,785
4.5%
7 HEADACHE 28,558
3.6%
8 NAUSEA 27,278
3.4%
9 DIARRHOEA 25,614
3.2%
10 RASH 25,503
3.2%
11 PSORIASIS 24,820
3.1%
12 PAIN IN EXTREMITY 24,453
3.1%
13 JOINT SWELLING 23,449
2.9%
14 INCORRECT DOSE ADMINISTERED 22,347
2.8%
15 MALAISE 21,522
2.7%
16 OFF LABEL USE 21,369
2.7%
17 NASOPHARYNGITIS 20,734
2.6%
18 CROHN^S DISEASE 19,769
2.5%
19 PYREXIA 19,166
2.4%
20 DEVICE ISSUE 18,060
2.3%
21 DRUG INTOLERANCE 17,334
2.2%
22 ALOPECIA 16,836
2.1%
23 VOMITING 16,590
2.1%
24 CONDITION AGGRAVATED 16,537
2.1%
25 INJECTION SITE HAEMORRHAGE 16,168
2.0%
26 ABDOMINAL PAIN 15,794
2.0%
27 PNEUMONIA 15,685
2.0%
28 DYSPNOEA 15,647
2.0%
29 PERIPHERAL SWELLING 15,337
1.9%
30 INJECTION SITE ERYTHEMA 15,205
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.